The role of human papillomavirus in the pathogenesis of head & neck squamous cell carcinoma: An overview

Infectious Agents and Cancer

Volumn 6, Issue 1, 2011, Pages

  Pannone, Giuseppe ^a   Santoro, Angela ^b,c   Papagerakis, Silvana ^d   Lo Muzio, Lorenzo ^a   De Rosa, Gaetano ^e   Bufo, Pantaleo ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b SANTA MARIA GORETTI HOSPITAL   (Italy)

^c UNIVERSITY OF BARI   (Italy)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STATISTICS; DISEASE FREE SURVIVAL; HEAD AND NECK CARCINOMA; OROPHARYNX CANCER; PAPILLOMAVIRUS INFECTION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA; WART VIRUS;

EID: 79953124785     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-6-4     Document Type: Review

References (83)

1. New perspectives in medical approach to therapy of head and neck squamous cell carcinoma. A Santarelli L Lo Russo F Bambini G Campisi L Lo Muzio, Minerva Stomatologica 2009 58 9 445 52 19893469
2. Cancer statistics. SH Landis T Murray S Bolden PA Wingo, CA Cancer J Clin 1998 48 6 29 10.3322/canjclin.48.1.6 9449931
3. SEER Cancer Statistics Review, 1975-2006. MJ Horner L R M Krapcho N Neyman R Aminou N Howlader SF Altekruse EJ Feuer L Huang A Mariotto BA Miller DR Lewis MP Eisner DG Stinchcomb BK Edwards eds, National Cancer Institute 1975 http://seer.cancer.gov/csr/1975-2006/ Bethesda, MD based on November 2008 SEER data submission, posted to the SEER web site, 2009
4. Changing patterns of tonsillar squamous cell carcinoma in the United States. M Frisch,, et al. Cancer Causes Control 2000 11 6 489 95 10.1023/A:1008918223334 10880031 (Pubitemid 30342838)
5. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. CH Shiboski BL Schmidt RC Jordan, Cancer 2005 103 9 1843 9 10.1002/cncr.20998 15772957 (Pubitemid 40563256)
6. The World Oral Health Report 2003. World Health Organization, Geneva: World Health Organization 2003 6 7
7. Squamous cell carcinoma of the oropharynx: influence of site of primary tumor. KA Pathak H Al Hajjaj NV Viallet DS Sutherland PD Kerr RW Nason, Oral abstracts/Oral Oncology 2009 Supplement 3 (1) 73 10.1016/j.oos.2009.06.136
8. A 25-Year Analysis of Veterans Treated for Tonsillar Squamous Cell Carcinoma. JJ Jaber J Moreira WJ Canar CM Bier-Laning, Arch Otolaryngol Head Neck Surg 2009 135 11 1147 115 10.1001/archoto.2009.164 19917929
9. Risk factors for oral cancer in newly diagnosed patients aged 45 years and younger: a case-control study in southern England. CD Llewellyn NW Johnson KA Warnakulasuriya, J Oral Pathol Med 2004 33 525 32 10.1111/j.1600-0714.2004. 00222.x 15357672 (Pubitemid 39318462)
10. The role of type of tobacco and type of alcoholic beverage in oral carcinogenesis. X Castellsague MJ Quintana MC Martinez A Nieto MJ Sanchez A Juan,, et al. Int J Cancer 2004 108 741 9 10.1002/ijc.11627 14696101 (Pubitemid 38076406)
11. Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers. ML Gillison KV Shah, Curr Opin Oncol 2001 13 183 8 10.1097/00001622-200105000-00009 11307062 (Pubitemid 32433975)
12. Human Papillomavirus Infection as a Prognostic Factor in Oropharyngeal Squamous Cell Carcinomas Treated in a Prospective Phase II Clinical Trial. S Jo A Juhasz K Zhang C Ruel S Loera SP Wilczynski,, et al. Anticancer Res 2009 29 5 1467 74 19443352
13. Role of human papillomavirus and its detection in potentially malignant and malignant head and neck lesions: updated review. AK Chaudhary M Singh S Sundaram R Mehrotra, Head Neck Oncol 2009 1 1 22 10.1186/1758-3284-1-22 19555477
14. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. AK Chaturvedi EA Engels WF Anderson ML Gillison, J Clin Oncol 2008 26 612 619 10.1200/JCO.2007.14.1713 18235120 (Pubitemid 351264356)
15. Immunohistochemical demonstration of human papilloma virus (HPV) antigens in oral squamous cell lesions. KJ Syrjänen S Pyrhönen SM Syrjänen MA Lamberg, Brit J Oral Surg 1983 21 2 147 53 6307342
16. A comparative light-microscopic, electron-microscopic and chemical study of human vaginal and buccal epithelium. IO Thompson P van der Bijl CW van Wyk AD van Eyk, Arch Oral Biol 2001 46 1091 1098 10.1016/S0003-9969(01)00082-6 11684027 (Pubitemid 33086338)
17. Combined effects of human papillomavirus-18 and N-methyl-N'-nitro-N- nitrosoguanidine on the transformation of normal human oral keratinocytes. KH Shin BM Min HM Cherrick NH Park, Mol Carcinog 1994 9 76 86 10.1002/mc.2940090205 8142012 (Pubitemid 24099078)
18. Papillomavirus infections and human genital cancer. H zur Hausen EM de Villiers L Gissmann, Gynecol Oncol 1981 12 124 128 10.1016/0090-8258(81)90067-6 6273261
19. The causal relation between human papillomavirus and cervical cancer. FX Bosch A Lorincz N Mũoz CJ Meijer KV Shah, J Clin Pathol 2002 55 244 265 11919208 (Pubitemid 34293391)
20. Human papillomavirus as a risk factor for oral squamous cell carcinoma: A meta-analysis, 1982-1997. CS Miller BM Johnstone, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology 2001 91 6 622 635 10.1067/moe.2001.115392 (Pubitemid 33601674)
21. The role of human papillomavirus in oral carcinogenesis. PK Ha JA Califano, Crit Rev Oral Biol Med 2004 15 188 96 10.1177/154411130401500402 15284184 (Pubitemid 44560780)
22. Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. W Li CH Thompson CJ O'Brien EB McNeil RA Scolyer YE Cossart,, et al. Int J Cancer 2003 106 553 8 10.1002/ijc.11261 12845651 (Pubitemid 36966212)
23. The effects of p53 status and human papillomavirus infection on the clinical outcome of patients with Stage IIIB cervical carcinoma treated with radiation therapy alone. H Ishikawa N Mitsuhashi H Sakurai K Maebayashi H Niibe, Cancer 2001 91 80 9 10.1002/1097-0142(20010101)91:1<80::AID-CNCR11>3.0. CO;2-E 11148563 (Pubitemid 32052617)
24. Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. H Mellin S Friesland R Lewensohn T Dalianis E Munck-Wikland, Int J Cancer 2000 89 300 4 10.1002/1097-0215(20000520)89: 3<300::AID-IJC14>3.0.CO;2-G 10861508 (Pubitemid 30430748)
25. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. C Fakhry WH Westra S Li,, et al. J Natl Cancer Inst 2008 100 4 261 9 10.1093/jnci/djn011 18270337 (Pubitemid 351480538)
26. Case-control study of human papillomavirus and oropharyngeal cancer. G D'Souza AR Kreimer,, et al. N Engl J Med 2007 356 19 1944 56 17494927 (Pubitemid 46740304)
27. Current concepts on human papillomavirus infections in children. S Syrjänen, APMIS 2010 118 6-7 494 509 20553530
28. Human Papillomavirus in Oral Exfoliated Cells and Risk of Head and Neck Cancer. EM Smith JM Ritchie KF Summersgill HT Hoffman DH Wang TH Haugen LP Turek, Journal of the National Cancer Institute 2004 96 6 15026470
29. Controversies surrounding human papillomavirus infection, head & neck vs oral cancer, implication for prophylaxis and treatment. G Campisi L Giovannelli, Head and Neck Oncology 2009 I 8 Commentary 10.1186/1758-3284-1-8
30. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Mũoz FX Bosch S de Sanjosé R Herrero X Castellsagué KV Shah International Agency for Research on Cancer Multicenter Cervical Cancer Study Group,, et al. N Engl J Med 2003 348 6 518 27 12571259 (Pubitemid 36159887)
31. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. AR Kreimer,, et al. Cancer Epidemiol Biomarkers Prev 2005 14 2 467 75 10.1158/1055-9965.EPI-04-0551 15734974 (Pubitemid 40270113)
32. HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007). N Termine,, et al. Ann Oncol 2008 19 10 1681 90 10.1093/annonc/mdn372 18558666
33. Human papillomavirus 6/11, 16 and 18 in oral carcinomas and benign oral lesions. Human papillomavirus infections and oral tumors. C Ostwald K Rutsatz J Schweder W Schmidt K Gundlach M Barten, Medical Microbiology and Immunology 2002 192 3 145 148 10.1007/s00430-002-0161-y 12920590
34. Human papillomavirus infections and oral tumors. Syrjänen Stina, Medical Microbiology and Immunology 2003 192 3 123 128 10.1007/s00430-002-0173-7 12920585
35. Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers. ML Gillison WM Koch RB Capone M Spafford W Westra L Wu,, et al. J Natl Cancer Inst 2000 92 9 709 720 10.1093/jnci/92.9.709 10793107 (Pubitemid 30365531)
36. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. J Mork,, et al. N Engl J Med 2001 344 15 1125 31 10.1056/NEJM200104123441503 11297703 (Pubitemid 32285233)
37. Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. BG Hansson,, et al. Acta Otolaryngol 2005 125 12 1337 44 10.1080/00016480510043945 16303684 (Pubitemid 41722001)
38. HPV infections and tonsillar carcinoma. S Syrjanen, J Clin Pathol 2004 57 5 449 55 10.1136/jcp.2003.008656 15113849 (Pubitemid 38621787)
39. Human papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implications. PT Hennessey WH Westra JA Califano, J Dent Res 2009 88 4 300 6 10.1177/0022034509333371 19407148
40. Demographic and risk factors in patients with head and neck tumors. R Tachezy J Klozar L Rubenstein E Smith M Salkov J Smahelov, et al. J Med Virol 2009 81 5 878 87 10.1002/jmv.21470 19319944
41. Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. JP Klussmann SJ Weissenborn U Wieland V Dries J Kolligs M Jungehuelsing,, et al. Cancer 2001 92 11 2875 84 10.1002/1097-0142(20011201) 92:11<2875::AID-CNCR10130>3.0.CO;2-7 11753961
42. Oral cancer prevention and control - the approach of the World Health Organization. PE Petersen, Oral Oncol 2009 45 4-5 454 60 10.1016/j.oraloncology. 2008.05.023 18804412
43. Human papillomavirus and oral cancer: the international agency for research on cancer multicenter study. R Herrero X Castellsague M Pawlita,, et al. J Natl Cancer Inst 2003 95 23 1772 1783 14652239 (Pubitemid 38008900)
44. HPV detection in head and neck cancer using the roche linear array HPV genotyping test. J Machado PP Reis T Zhang C Simpson W Xu B Perez-Ordonez, Oral abstracts/Oral Oncology 2009 Supplement 3 (1)
45. Double demonstration of oncogenic HPV DNA and HPV-E7 protein in 8.57% of oral cancers. Preliminary report. G Pannone P Bufo A Santoro SM Papagerakis C Rubini L Lo Muzio, Oral abstracts/Oral Oncology 2009 Supplement 3 (1)
46. Low prevalence of human papillomavirus in squamous-cell carcinoma limited to oral cavity proper. L Scapoli A Palmieri C Rubini M Martinelli G Spinelli F Ionna,, et al. Mod Pathol 2009 22 3 366 72 10.1038/modpathol.2008.180 18978731
47. Progressive increase of human papillomavirus carriage rates in potentially malignant and malignant oral disorders with increasing malignant potential. K Szarka I Tar E Fehér T Gll A Kis ED Táth,, et al. Oral Microbiol Immunol 2009 24 4 314 8 10.1111/j.1399-302X.2009.00516.x 19572894
48. Is the human papillomavirus a mutual aetiological agent in oral and cervical squamous cell carcinoma? TC Postma WF Van Heerden, Anticancer Res 2003 23 4 3509 12 12926099 (Pubitemid 36975458)
49. Oral squamous cell carcinoma; from an hypothesis about a virus, to concern about possible sexual transmission. C Scully, Oral Oncol 2002 38 227 34 10.1016/S1368-8375(01)00098-7 11978544 (Pubitemid 34442543)
50. The role of the E6-p53 interaction in the molecular pathogenesis of HPV. M Thomas D Pim L Banks, Oncogene 1999 18 7690 700 10.1038/sj.onc.1202953 10618709 (Pubitemid 30052696)
51. Mechanism of genomic instability in cells infected with the high-risk human papillomaviruses. M Kadaja H Isok-Paas T Laos E Ustav M Ustav, PLoS Pathog 2009 5 4 10.1371/journal.ppat.1000397 19390600
52. Molecular characterization of HPV16-associated squamous cell carcinomas of the oropharynx and larynx. D Holzinger G Halec M Schmitt M Pawlita FX Bosh, Oral Onc 2009 supplement 3 (1) 122 10.1016/j.oos.2009.06.284
53. Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck. WJ Koskinen,, et al. Int J Cancer 2003 107 3 401 6 10.1002/ijc.11381 14506740 (Pubitemid 37266460)
54. Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. H Mellin,, et al. Int J Cancer 2002 102 2 152 8 10.1002/ijc.10669 12385011 (Pubitemid 35168028)
55. Prevalence of human papillomavirus (HPV) in oral cavity and in oropharynx. T Peixoto PG Castro I Bussoloti Filho, Rev Bras Otorinolaringol 2006 72 2 272 282 (Pubitemid 44313655)
56. PCR detection of human papillomavirus of the mucosa: comparison between MY09/11 and GP5+/6+ primer sets. TW Remmerbach,, et al. J Clin Virol 2004 30 4 302 8 10.1016/j.jcv.2003.12.011 15163418 (Pubitemid 38649097)
57. Short-fragment PCR assay for highly sensitive broad-spectrum detection of human papillomaviruses in laryngeal squamous cell carcinoma and normal mucosa: clinico-pathological evaluation. K Morshed M Polz-Dacewicz M Szymajski Polz Dorota, Eur Arch Otorhinolaryngol 2008 265 Suppl 1 89 S96 10.1007/s00405-007- 0569-5 18193443
58. The WHOHPV LabNet international proficiency study of HPV typing methods. C Eklund T Zhou J Dillner, The 25th international Papillomavirus Conference: 8-14th May 2009, Malmö, Sweden This conforms to the requirements of the World Health Organization for the proficient detection of HPV DNA
59. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. M Serrano GJ Hannon D Beach, Nature 1993 366 704 7 10.1038/366704a0 8259215 (Pubitemid 24036021)
60. CDK inhibitors: positive and negative regulators of G1-phase progression. CJ Sherr JM Roberts, Genes Dev 1999 13 1501 12 10.1101/gad.13.12.1501 10385618 (Pubitemid 29297917)
61. Phenotypic alterations in Rb pathway have more prognostic influence than p53 pathway proteins in oral carcinoma. R Jayasurya KM Sathyan K Lakshminarayanan,, et al. Mod Pathol 2005 18 1056 66 10.1038/modpathol.3800387 15731778 (Pubitemid 41224496)
62. p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters. CA Fischer M Kampmann I Zlobec E Green L Tornillo A Lugli M Wolfensberger LM Terracciano, Ann Oncol 2010 21 10 1961 6 10.1093/annonc/mdq210 20423915
63. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. AL Reed J Califano P Cairns,, et al. Cancer Res 1996 56 3630 3 8705996 (Pubitemid 26272001)
64. Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines. JE Burns,, et al. Br J Cancer 1993 67 6 1274 84 10.1038/bjc.1993.238 8390283 (Pubitemid 23172865)
65. Frequent mutations of p53 gene in oesophageal squamous cell carcinomas with and without human papillomavirus (HPV) involvement suggest the dominant role of environmental carcinogens in oesophageal carcinogenesis. F Chang,, et al. Br J Cancer 1994 70 2 346 51 10.1038/bjc.1994.305 8054284 (Pubitemid 24247162)
66. HPV & head and neck cancer: a descriptive update. PKC Goon MA Stanley J Ebmeyer L Steinsträsser T Upile W Jerjes M Bernal-Sprekelsen M Görner HH Sudhoff, Head & Neck Oncology 2009 1 36
67. Molecular classification identifies a subset of human papillomavirus - associated oropharyngeal cancers with favorable prognosis. PM Weinberger,, et al. J Clin Oncol 2006 24 5 736 47 10.1200/JCO.2004.00.3335 16401683 (Pubitemid 46622040)
68. Human papillomavirus and oropharyngeal cancer: what you need to know in 2009. MB Gillespie S Rubinchik B Hoel N Sutkowski, Curr Treat Options Oncol 2009 10 5-6 296 307 10.1007/s11864-009-0113-5 19768554
69. Phenotypic alterations in Rb pathway have more prognostic influence than p53 pathway proteins in oral carcinoma. R Jayasurya KM Sathyan K Lakshminarayanan,, et al. Mod Pathol 2005 18 1056 66 10.1038/modpathol.3800387 15731778 (Pubitemid 41224496)
70. Fundamental Differences in Cell Cycle Deregulation in Human Papillomavirus-Positive and Human Papillomavirus-Negative Head/Neck and Cervical Cancers. D Pyeon MA Newton PF Lambert JA den Boon S Sengupta CJ Marsit CD Woodworth JP Connor TH Haugen EM Smith KT Kelsey LP Turek P Ahlquist, Cancer Research 2007 67 10 4605 4619 10.1158/0008-5472.CAN-06-3619 17510386 (Pubitemid 46910165)
71. Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. RJ Slebos Y Yi K Ely,, et al. Clin Cancer Res 2006 12 3 Pt 1 701 9 10.1158/1078-0432.CCR-05-2017 16467079 (Pubitemid 43259848)
72. HPV31 E7 facilitates replication by activating E2F2 transcription through its interaction with HDACs. MS Longworth R Wilson LA Laimins, EMBO J 2005 24 1821 30 10.1038/sj.emboj.7600651 15861133 (Pubitemid 40769501)
73. The expression of key cell cycle markers and presence of human papillomavirus in squamous cell carcinoma of the tonsil. W Li CH Thompson YE Cossart,, et al. Head Neck 2004 26 1 9 10.1002/hed.10335 14724900 (Pubitemid 38030143)
74. Human papillomaviruses in head and neck cancer: 8 year-survival-analysis of 73 patients. M Hoffmann T Gorogh S Gottschlich,, et al. Cancer Lett 2005 218 199 206 10.1016/j.canlet.2004.09.027 15670897 (Pubitemid 40164721)
75. Computer-assisted analysis of p53 and PCNA expression in oral lesions infected with human papillomavirus. Christiane Pienna Soares Carlos Benatti Neto Paula Andrea Gabrielli Fregonezi Debora Barreto Teresa Raimunda Telma de Macedo Santos Adhemar Longatto Filho Marina Yoshi Sakamoto Maeda, Anal Quant Cytol Histol 2003 25 1 19 24 12630078 (Pubitemid 36231906)
76. Transcriptional Activation of Cyclin D1 Promoter by FAK Contributes to Cell Cycle Progression. J Zhao R Pestell JL Guan, MBOC 2001 12 12 4066 4077 (Pubitemid 34001092)
77. Chromosome in situ hybridisation, Ki-67, and telomerase immunocytochemistry in liquid based cervical cytology. Y Cheung PM Chiu KL Tsun US Khoo BSY Leung HYS Ngan, A N J Clin Pathol 2004 57 7 721 727 10.1136/jcp.2003.013730 (Pubitemid 38901487)
78. Molecular characterization of HPV16-associated squamous cell carcinomas of the oropharynx and larynx. D Holzinger G Halec M Schmitt M Pawlita FX Bosch, Oral abstracts/Oral Oncology 2009 Supplement 3 (1) 122 10.1016/j.oos.2009.06.284
79. Presence of HPV DNA in convalescent salivary rinses is an adverse prognostic marker in head and neck squamous cell carcinoma. AY Chuang,, et al. Oral Oncol 2008 44 10 915 9 10.1016/j.oraloncology.2008.01.001 18329326
80. Feasibility of quantitative PCR-based saliva rinse screening of HPV for head and neck cancer. M Zhao,, et al. Int J Cancer 2005 117 4 605 10 10.1002/ijc.21216 15929076 (Pubitemid 41504548)
81. Salivary Transcriptome Diagnostics for Oral Cancer Detection. Yang Li Maie AR St John Xiaofeng Zhou Yong Kim Uttam Sinha Richard CK Jordan David Eisele Elliot Abemayor David Elashoff No-Hee Park David T Wong, Clinical Cancer Research 2004 10 8442 8450 10.1158/1078-0432.CCR-04-1167 15623624 (Pubitemid 40053408)
82. Proteomics Analysis of Cells in Whole Saliva from Oral Cancer Patients via Value-added Three-dimensional Peptide Fractionation and Tandem Mass Spectrometry. Hongwei Xie Getiria Onsongo Jonathan Popko Ebbing P de Jong Cao Jing John V Carlis Robert J Griffin Nelson L Rhodus Timothy J Griffin, Molecular & Cellular Proteomics 2008 7 486 498 (Pubitemid 351472459)
83. The aetiopathogenesis of HPV in malignant disease: evidence for a global immunization programme. MS Miah RA Crosbie RE Mountain S Mahendran, Oral abstracts/Oral Oncology 2009 Supplement 3 (1) 121 122 10.1016/j.oos.2009.06.282